Impact of genetics on the diagnosis and clinical management of syndromic craniosynostoses.

Abstract excerpt

PURPOSE: More than 60 different mutations have been identified to be causal in syndromic forms of craniosynostosis. The majority of these mutations occur in the fibroblast growth factor receptor 2 gene (FGFR2). The clinical management of syndromic craniosynostosis varies based on the particular causal mutation. Additionally, the diagnosis of a patient with syndromic craniosynostosis is based on the clinical...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acrocephalosyndactylia
• Share to Craniosynostoses